AGTC Working Capital Per Revenue	(Sep 30 2022) I. Quarter	(Jun 30 2022) IV. Quarter	(Mar 31 2022) III. Quarter	(Dec 31 2021) II. Quarter	(Sep 30 2021) I. Quarter
Y / Y Working Capital Change	-85.16 %	-72.94 %	-53.65 %	25.21 %	29.08 %
Y / Y Revenue Change	-	-35 %	-	-	-
Working Capital Per Revenue	100.74	147.69	128.82	154.7	149.54
Working Capital Per Revenue Ranking	#	#	#	#	#
Seq. Working Capital Change	-56.33 %	-45.54 %	-12.75 %	-28.49 %	-20.35 %
Seq. Revenue Change	-	-	-	-	-

New: More AGTC's historic Working Capital Per Revenue Ratios >>

Financial strength information for the Biotechnology & Pharmaceuticals industry >> Back to AGTC Financial Strength Comparisons >> See AGTC Balance Sheets

Comment on AGTC's Working Capital Per Revenue in the first quarter 2022

Applied Genetic Technologies's Working Capital Per Revenue in the Q1 2022 sequentially fell to 100.74 but remained above Applied Genetic Technologies's average.

Within Healthcare sector Applied Genetic Technologies Corporation has achieved the lowest Working Capital Per Revenue. While Working Capital Per Revenue remained unchanged in the Q1 2022 relative to the prior quarter at no. .

Working Capital Per Revenue Ranking
Within:	No.
Industry	#
Sector	#
S&P 500	#

Working Capital Per Revenue Statistics
High	Average	Low
0	0	0

Financial Statements
Applied Genetic Technologies's Working Capital	$ 11 Millions	Visit AGTC's Balance sheet
Applied Genetic Technologies's Revenues	$ 0 Millions	Visit AGTC's Income Statement
Where are AGTC's Sales coming from?		Visit AGTC's Sales by Geography

Companies with similar Average Working Capital Per Revenue for 12 months ending Sep 30 2022, within Healthcare Sector	Working Capital Per Revenue
Tff Pharmaceuticals Inc	274.28
Sage Therapeutics Inc	238.82
Traws Pharma inc	198.10
Biorestorative Therapies Inc	162.93
Inmune Bio Inc	159.15
Reata Pharmaceuticals Inc	148.85
Crispr Therapeutics Ag	145.72
Viridian Therapeutics Inc	120.74
4d Molecular Therapeutics Inc	116.83
Absci Corp	106.71
Anaptysbio inc	105.39
Fusion Pharmaceuticals Inc	103.10
Mirati Therapeutics Inc	100.98
Prothena Corporation Public Limited Company	98.26
Pasithea Therapeutics Corp	96.84
Geron Corp	96.34
Oragenics Inc	93.01
Janux Therapeutics Inc	84.19
Vbi Vaccines Inc	83.28
Cardiff Oncology Inc	82.26
Imunon Inc	76.07
Astrotech Corp	74.01
Longeveron Inc	69.92
Caribou Biosciences Inc	69.53
Neuroone Medical Technologies Corp	69.14
Actinium Pharmaceuticals Inc	68.69
Lumos Pharma Inc	68.13
Crinetics Pharmaceuticals Inc	67.61
Q32 Bio Inc	64.06
Synlogic Inc	63.93

Date modified: 2023-03-25T11:17:14+00:00

Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright � 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com